Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-05-02 @ 7:25 AM
Study NCT ID:
NCT03167151
Status:
TERMINATED
Last Update Posted:
2020-07-31
First Post:
2017-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Sponsor:
University of Oxford
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-muscle Invasive Bladder Cancer (NMIBC) | View |